<DOC>
	<DOCNO>NCT02548208</DOCNO>
	<brief_summary>The study single-center , double blind , randomize controlled trial aim investigate effect focus extracorporeal shockwave therapy ( fESWT ) Delayed Onset Muscle Soreness ( DOMS ) non-dominant biceps brachialis muscle healthy voluntary adult .</brief_summary>
	<brief_title>Single Focused Shock Wave Release od Delayed Onset Muscle Soreness ( DOMS )</brief_title>
	<detailed_description>Forty-five participant agree participate sign write informed consent . After enrollment , muscle soreness induce participant subsequently randomize receive either ( 1 ) focus extracorporeal shockwave therapy ( Verum ) , ( 2 ) sham shock wave ( Sham ) ( 3 ) treatment ( Control ) . Thereafter , treatment administer , . Measures repeat treatment 24 , 48 72 hour . Main outcome parameter pain intensity rest movement assess visual analogue scale ( VAS ) elbow region non-dominant arm . Secondary outcome include pressure pain threshold ( PPT ) biceps muscle belly , maximum isometric voluntary force ( MIVF ) elbow flexor assess impairment activity daily live . Participants followed-up 72 hour induction Delayed Onset Muscle Soreness .</detailed_description>
	<mesh_term>Musculoskeletal Pain</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Athletic Injuries</mesh_term>
	<criteria>healthy subject age 18+ voluntariness pain pregnancy musculoskeletal disease systemic neurological disease cancer coagulation disorder mental illness drug addiction allergy ultrasound gel cardiac illness vascular disease limbs central nervous system regional scar regional skin transplant hypoesthesia allergic form acute dermatitis chronic intake analgesic , neuroleptic , antidepressant , corticoid alpha2blockers current state delay onset muscle soreness extracorporeal shockwave therapy within last 2 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>